Finsbury Growth & Income Trust: Board action puts shareholder value in focus

FGT
[shareaholic app="share_buttons" id_name="post_below_content"]

Finsbury Growth & Income Trust is a long-established UK investment trust with an experienced manager, a focused portfolio and a board that is now taking active steps to improve shareholder value.

The trust was launched a century ago and has been managed since 2000 by Nick Train at Lindsell Train. For much of the first 20 years of his tenure, the strategy delivered strong results against the UK market. Its portfolio was built around a small number of quality growth companies, mainly in the UK, with a clear leaning towards consumer names.

Recent years have been more challenging, but the reasons are easy to understand. Since 2021, market leadership has favoured cyclical and value stocks, while Finsbury Growth & Income Trust’s quality growth style has faced a less supportive backdrop. Some long-term holdings have also had company-specific issues. With around 20 holdings, the trust’s concentrated structure means individual stock outcomes can have a meaningful effect on overall returns. That concentration increases risk, but it also gives successful decisions the potential to make a significant difference.

The important development for investors is that the trust now has a renewed mandate and a clearer value focus. At the January 2026 annual general meeting, shareholders voted strongly in favour of continuation, with more than 97% supporting the trust’s future.

The board’s response also adds to the investment case. It has expressed confidence that the managers’ strategy can lead to improved performance and has committed to doing whatever it takes to improve shareholder value. That matters because the trust is not relying only on a change in market conditions. The board is also taking ownership of the actions within its control, including policy measures that can help support investor confidence.

Finsbury Growth & Income Trust Plc (LON:FGT) invests in the shares of predominantly UK-listed companies, with the objective of achieving capital and income growth. 

Share on:
Find more news, interviews, share price & company profile here for:

    If our articles help you then why not add us as a preferred news source on Google.

    Finsbury Growth & Income Trust highlights portfolio value in May

    Finsbury Growth & Income Trust noted that more than 50% of the portfolio is invested in companies subject to corporate activity in 2026, pointing to potential value across its holdings. Intertek rose 15% in May following takeover interest, while the Trust’s NAV total return was -1.7% and the share price total return was -1.8% against a 1.2% gain for the FTSE All-Share Index.

    Unilever’s US innovation centre sharpens its beauty growth strategy

    Unilever’s US$270 million New Haven innovation centre strengthens its focus on faster beauty, wellbeing and personal care product development.

    Finsbury Growth & Income Trust sharpens its investor proposition

    Finsbury Growth & Income Trust is lifting its dividend, lowering fees and increasing investment flexibility as it strengthens its appeal to long-term UK equity investors.

    Finsbury Growth & Income Trust enhances dividend policy and increases gearing

    Finsbury Growth & Income outlines measures to improve shareholder returns, including a higher quarterly dividend, fuller use of its borrowing facility, reduced management fees and continued focus on long-term UK equity opportunities.

    Finsbury Growth & Income Trust delivers strong April NAV gain

    Finsbury Growth & Income Trust’s NAV rose 6.1% in April 2026, supported by gains from London Stock Exchange Group, Intertek and RELX, with the manager highlighting portfolio exposure to high-quality businesses and AI-related data opportunities.

    Unilever’s AI investment adds weight to beauty growth plans

    Unilever’s use of AI in Beauty & Wellbeing highlights how technology is becoming central to faster innovation and stronger consumer relevance.

    Search

    Search